Detalles de la búsqueda
1.
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study.
Support Care Cancer
; 32(5): 281, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598052
2.
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.
Acta Oncol
; 62(1): 62-69, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645166
3.
A national repository of complete radiotherapy plans: design, Results, and experiences.
Acta Oncol
; 62(10): 1161-1168, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850659
4.
2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting.
Support Care Cancer
; 32(1): 26, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097904
5.
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation.
Support Care Cancer
; 32(1): 53, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129530
6.
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Support Care Cancer
; 32(1): 37, 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110581
7.
Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences.
Support Care Cancer
; 30(2): 1181-1190, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453567
8.
Response to Vitetta et al.
Support Care Cancer
; 30(11): 8623-8624, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100727
9.
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Support Care Cancer
; 25(1): 297-301, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27572335
10.
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
Support Care Cancer
; 25(1): 309-316, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27624464
11.
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 17(4): 509-518, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26952945
12.
Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish, observational melanoma study.
Eur J Cancer
; 205: 114099, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754294
13.
Organ-specific accuracy of [18F]FDG-PET/CT in identifying immune-related adverse events in patients with high-risk melanoma treated with adjuvant immune checkpoint inhibitor.
Jpn J Radiol
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504000
14.
Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.
Eur J Cancer
; 202: 114023, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518533
15.
Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study.
Support Care Cancer
; 21(12): 3425-31, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23949739
16.
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.
Cancers (Basel)
; 13(21)2021 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771712
17.
Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults.
Expert Rev Clin Pharmacol
; 12(7): 661-680, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31194593
18.
New treatments on the horizon for chemoradiotherapy-induced nausea and vomiting.
Expert Opin Pharmacother
; 17(12): 1623-9, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322893
19.
Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy.
Radiother Oncol
; 117(2): 333-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26372344
20.
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Expert Rev Anticancer Ther
; 12(2): 139-50, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22316362